AstraZeneca - Asia Tech Wire

AstraZeneca

2025.02.01

00:22

UK government: Changes to AstraZeneca's (AZN.O) initial proposed investment structure resulted in a reduction in the amount of government funding.

2025.01.03

14:24

The first in China, Tagrisso was approved for the treatment of EGFR mutation stage III unresectable non-small cell lung cancer

On January 2, AstraZeneca announced that the National Medical Products Administration has approved its drug Tagrisso (generic name: osimertinib mesylate tablets) for the treatment of adult patients with locally advanced, unresectable (stage III) non-small cell lung cancer (NSCLC) who have not experienced disease progression during or after platinum-containing chemoradiotherapy and have epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 (L858R) substitution mutations. It has also become the first and only targeted treatment option approved in China for stage III unresectable non-small cell lung cancer with EGFR mutations.

2024.12.20

09:10

Beijing Mayor Yin Yong meets with AstraZeneca's global CEO via video link

According to Beijing Yizhuang WeChat official account, on the afternoon of December 19, Beijing Mayor Yin Yong met with AstraZeneca's global CEO Soriot via video. Yin Yong said that the Chinese market has huge scale and development space, and it is still very attractive to companies from all countries. Beijing has rich medical science and education and clinical resources, strong demand in the medical and health market, and a booming pharmaceutical industry. In recent years, we have taken the pharmaceutical and health industry as an important direction for the development of high-end industries, accelerated the construction of high-level research hospitals, vigorously developed innovative drugs and medical devices, carried out pilot reforms in the field of medicine and health, and committed to building an ecological system for the entire industry chain, forming a spatial pattern of coordinated pharmaceutical and health industry development in the north and south. It is hoped that AstraZeneca will make full use of Beijing's advantages in basic medical research and industrial development, expand its R&D and industrial layout in Beijing, strengthen R&D cooperation with local universities, scientific research institutions, enterprises and other innovative entities, promote the implementation and transformation of more scientific and technological achievements in Beijing, and achieve a higher level of mutual benefit and win-win results.

2024.12.05

11:30

AstraZeneca China personnel adjustment, Lin Xiao appointed as AstraZeneca China General Manager

According to the 21st Century Business Herald, the reporter learned that Iskra Reic, the new global executive vice president and head of international business of AstraZeneca, issued an internal letter announcing that Lin Xiao will serve as the general manager of AstraZeneca China and Guan Dongmei will serve as the general manager of AstraZeneca China's oncology business. Lin Xiao and Guan Dongmei will become members of the global management team of the biopharmaceutical business unit and the oncology business unit respectively. Lin Xiao, Guan Dongmei, and Hu Yiqing, vice president of AstraZeneca China and head of the rare disease business unit, will all report directly to Iskra Reic, the global executive vice president and head of international business of AstraZeneca. In addition, according to AstraZeneca's disclosure to reporters, Lai Minglong serves as the head of AstraZeneca's global oncology business Dato-DXd and lung cancer business unit, and reports to Mr. Sunil Verma, AstraZeneca's global senior vice president and head of the oncology business unit.

2024.10.31

03:02

AstraZeneca's China president under investigation in China

Asia Tech Wire (Oct 31) -- AstraZeneca plc said Wednesday that Leon Wang, executive vice president for international and AstraZeneca China president, is cooperating with Chinese authorities in an investigation.

2024.10.25

08:06

BeiGene Greater China CCO said to be under investigation

Asia Tech Wire (Oct 25) -- Chinese biotech firm BeiGene's (BGNE:NASDAQ; 6160.HK) chief commercial officer for Greater China, Eva Yin, is said to be under investigation by Chinese regulators, according to recent market rumors.

2024.05.22

07:44

AstraZeneca to build separate supply chain in China

Asia Tech Wire (May 22) -- British-Swedish drugmaker AstraZeneca plc will create a separate supply chain in China, according to the Financial Times.

2024.05.20

06:54

AstraZeneca to invest $1.5 billion to build plant in Singapore

Asia Tech Wire (May 20) -- British drugmaker AstraZeneca said Monday it will invest $1.5 billion to build a manufacturing site in Singapore specializing in antibody-drug conjugates (ADCs).

2021.11.17

11:25

Malaysia approves Sinovac, AstraZeneca's COVID-19 vaccines as booster shots

Asian Tech Press (Nov 17) -- Malaysia has conditionally approved Sinovac and AstraZeneca's COVID-19 vaccines as booster shots.

2021.11.03

05:32

AstraZeneca to invest an additional $90 million in Vietnam for drug production

Asian Tech Press (Nov 03) -- According to the Vietnamese government website, AstraZeneca will invest an additional $90 million in Vietnam to help the country improve its pharmaceutical production capacity.

2021.09.14

09:01

Japan to provide 1.3 mln doses of AstraZeneca vaccine to Asian countries

Asian Tech Press (Sep 14) -- Japan plans to provide an additional 1.3 million doses of AstraZeneca COVID-19 vaccine to Asian countries, Japan's Foreign Minister Toshimitsu Motegi said at Tuesday's press conference, Russia's Sputnik reported.

2021.08.04

04:31

Sinovac's COVID-19 vaccine was 58.5% effective, Chilean health authorities say

SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

2021.07.14

08:04

Thailand mulls regulate export volume of AstraZeneca vaccine

Thailand is mulling over regulating the volume of locally produced AstraZeneca COVID-19 vaccine for export, according to Reuters.

2021.06.25

15:00

Japan to donate millions more AstraZeneca vaccine doses across Asia

Japan will donate 1 million coronavirus vaccine doses each to Indonesia, Malaysia, the Philippines and Thailand starting next week, Foreign Minister Toshimitsu Motegi said Friday.

2021.06.04

15:00

877,000 doses of Korean-made AstraZeneca vaccine shipped

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03